Literature DB >> 1736330

Fractionation response and repair kinetics of radiation-induced heart failure in the rat.

S Schultz-Hector1, M Sund, H D Thames.   

Abstract

Local heart irradiation with single or fractionated doses leads to heart failure after dose-dependent latency times. Clinical symptoms of heart failure are dyspnoea at rest, apathy and subcutaneous oedema. Animals autopsied when they presented with these symptoms, have a congested liver and occasional pleural effusions. The left ventricle is dilated, showing a reduction in wall thickness by 15-17% of control values. Histological examination reveals a focal degeneration and necrosis of about 23% of the total myocardial volume. Loss of alkaline phosphatase activity from myocardial capillaries, which is known to precede myocardial degeneration, involves 77% of the myocardium. These findings at the time of manifest heart failure are constant, independent on whether injury to the heart was inflicted by single-dose or fractionated irradiation or whether heart failure developed within a relatively short time after high total doses or within many months after low total doses. The latent time of heart failure therefore can be considered an appropriate endpoint for comparison of treatment groups. From experiments giving 1, 2, 4, or 10 dose fractions, a low alpha/beta ratio of 3.7 Gy (95% confidence interval 1.8-5.6 Gy) can be calculated. When the time interval between dose fractions is varied in a split-dose experiment, time intervals of up to 3 h do not increase the survival time significantly. This appears to indicate very slow repair of sublethal damage. On the other hand, it cannot be excluded that pathogenetic mechanisms independent of cell death in the renewing cell population contribute to this effect, making an interpretation of the alpha/beta ratio in terms of cell survival parameters of a defined target cell population difficult.

Entities:  

Mesh:

Year:  1992        PMID: 1736330     DOI: 10.1016/0167-8140(92)90303-c

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  16 in total

Review 1.  Radiation-induced cardiovascular injury.

Authors:  Jolyon H Hendry; M Akahoshi; Li Sheng Wang; Steven E Lipshultz; Fiona A Stewart; Klaus R Trott
Journal:  Radiat Environ Biophys       Date:  2008-01-10       Impact factor: 1.925

Review 2.  Effects of ionizing radiation on the heart.

Authors:  Marjan Boerma; Vijayalakshmi Sridharan; Xiao-Wen Mao; Gregory A Nelson; Amrita K Cheema; Igor Koturbash; Sharda P Singh; Alan J Tackett; Martin Hauer-Jensen
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-10       Impact factor: 5.657

3.  Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Robert T Dess; Yilun Sun; Martha M Matuszak; Grace Sun; Payal D Soni; Latifa Bazzi; Venkatesh L Murthy; Jason W D Hearn; Feng-Ming Kong; Gregory P Kalemkerian; James A Hayman; Randall K Ten Haken; Theodore S Lawrence; Matthew J Schipper; Shruti Jolly
Journal:  J Clin Oncol       Date:  2017-03-16       Impact factor: 44.544

4.  Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970-2009.

Authors:  Frances K Duane; Naomi B Boekel; Judy N Jacobse; Zhe Wang; Berthe M P Aleman; Sarah C Darby; Michael Schaapveld; Flora E van Leeuwen; Margreet H A Baaijens; Samantha Warren; Carolyn W Taylor
Journal:  Clin Transl Radiat Oncol       Date:  2022-07-16

Review 5.  Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms.

Authors:  M P Little; E J Tawn; I Tzoulaki; R Wakeford; G Hildebrandt; F Paris; S Tapio; P Elliott
Journal:  Radiat Environ Biophys       Date:  2009-10-28       Impact factor: 1.925

6.  A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with (90)Y-ibritumomab tiuxetan (Zevalin).

Authors:  Massimiliano Pacilio; Margherita Betti; Francesco Cicone; Carolina Del Mastro; Livia Montani; Laura Chiacchiararelli; Alessia Monaco; Enrico Santini; Francesco Scopinaro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

7.  Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage.

Authors:  Shun-Ying Hu; Hai-Feng Duan; Qing-Fang Li; Yue-Feng Yang; Jin-Long Chen; Li-Sheng Wang; Hua Wang
Journal:  Acta Pharmacol Sin       Date:  2009-09-14       Impact factor: 6.150

Review 8.  Radiation-related heart disease: current knowledge and future prospects.

Authors:  Sarah C Darby; David J Cutter; Marjan Boerma; Louis S Constine; Luis F Fajardo; Kazunori Kodama; Kiyohiko Mabuchi; Lawrence B Marks; Fred A Mettler; Lori J Pierce; Klaus R Trott; Edward T H Yeh; Roy E Shore
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

9.  Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.

Authors:  Kyle Wang; Michael J Eblan; Allison M Deal; Matthew Lipner; Timothy M Zagar; Yue Wang; Panayiotis Mavroidis; Carrie B Lee; Brian C Jensen; Julian G Rosenman; Mark A Socinski; Thomas E Stinchcombe; Lawrence B Marks
Journal:  J Clin Oncol       Date:  2017-01-23       Impact factor: 50.717

10.  A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure.

Authors:  Mark P Little; Anna Gola; Ioanna Tzoulaki
Journal:  PLoS Comput Biol       Date:  2009-10-23       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.